Moss Genomics Inc. News Releases

Moss Genomics Reports Bitcoin Cash (BCH) Mining Activity

Mon, 05 Jan 2026 09:29:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - January 5, 2026) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (OTCQB: MSSGF) (the "Company" or "Moss") has announced it has mined a block on the Bitcoin Cash ("BCH") blockchain using proprietary mining infrastructure operated by the Company. BCH block #931,986 was mined on Jan 1, 2026 with miner ID "MOSS" included in the coinbase signature.This mining activity represents the Company's first operation in the Bitcoin ecosystem. As a team with founding...

Moss Genomics Announces Closing of Financing Round

Wed, 12 Nov 2025 19:01:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - November 12, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (OTCQB: MSSGF) (the "Company" or "Moss") announces that, effective as of November 11, 2025, it has closed a non-brokered private placement of 555,555 common shares at $0.18 per share for gross proceeds of $100,000. No finder's fees were paid. Net proceeds will be used for general working capital.In addition, effective as of November 11, 2025, Moss issued an aggregate 5,164,213 common...

Moss Genomics Advances Blockchain Integration Strategy

Thu, 10 Jul 2025 19:33:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - July 10, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (OTCQB: MSSGF) (the "Company" or "Moss") is providing an update on its Ethereum (ETH) Treasury Strategy. As part of this strategy, the Company has contributed 200 ETH with a commitment to contribute an additional 800 ETH to the presale of STRAT, an on-chain smart contract that enables ETH-based capital flows through algorithmic expansion and redemption mechanisms.This contribution...

Moss Genomics Announces Strategic Investment in Genomes.io

Thu, 19 Jun 2025 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - June 19, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (OTCQB: MSSGF) (the "Company" or "Moss") is pleased to announce that on June 18, 2025, it has entered into a non-binding term sheet for a strategic, non-controlling equity investment in Genomes.io Ltd. ("Genomes.io"), a UK-based company focused on secure, user-owned genomic data storage leveraging blockchain infrastructure.Under the terms of the proposed investment, Moss would acquire a...

Moss Genomics Launches "Perennial" Genomics Platform, Closes on 130 ETH

Mon, 28 Apr 2025 07:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - April 28, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (OTCQB: MSSGF) (the "Company" or "Moss") is pleased to announce the public launch of its genomics platform "Perennial", and closing on 130 ETH as part of its ongoing private placement.Public Launch of PerennialMoss is pleased to announce the public launch of its new genomics platform, "Perennial". The platform allows users to upload standard blood test results and receive deep insights...

Moss Genomics Announces Listing on the OTC Markets

Fri, 11 Apr 2025 07:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - April 11, 2025) - Moss Genomics Inc. (CSE: MOSS) (OTCQB: MSSGF) (FSE: F73) (the "Company" or "Moss") is pleased to announce that its common shares are now listed for trading on the OTC Markets under the ticker MSSGF. This milestone significantly expands Moss's accessibility for U.S.-based investors and enhances overall share liquidity by enabling trading through U.S. broker-dealers.The listing on the OTC Markets is part of Moss's broader strategy to...

Moss Genomics Inc. Announces Leadership Changes

Wed, 26 Feb 2025 09:00:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - February 26, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) ("Moss" or the "Company") is pleased to announce the appointment of Joseph De Pinto to its Board of Directors and Michal "Mickey" Goldstein as its new fractional Chief Financial Officer (CFO).Having served as a co-founder in several blockchain-based companies as well as Barpay, which pioneered digital payments at over 15,000 bars and restaurants over the past decade, Mr. De Pinto brings...

Moss Genomics Announces Genomics Business Update, Integrating Blockchain for Genomic Security and Transparency

Tue, 25 Feb 2025 09:00:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - February 25, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (the "Company" or "Moss Genomics") is pleased to provide an update on its business strategy and the continued development of its genomics-focused initiatives. As the Company advances its product roadmap, it remains committed to leveraging blockchain technology within its genomics platform while maintaining an Ethereum accumulation strategy as part of its treasury management.Moss Genomics...

Moss Genomics Announces Private Placement and Agreement to Acquire Ethereum

Mon, 03 Feb 2025 19:24:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - February 3, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (the "Company" or "Moss") is pleased to announce a non-brokered private placement of up to 2,000,000 common shares at price of $0.18 per share for aggregate proceeds of up to $360,000 (the "Offering"). The Offering may close in one or more tranches and is subject to the approval of the Canadian Securities Exchange (the "Exchange"). Additionally, the Company may pay finders' fees in...

Moss Genomics Announces Closing of Private Placement, Acquisition of 160 Ethereum Cryptocurrency (ETH) and Welcomes Hunter Jordan to Its Board of Directors

Fri, 31 Jan 2025 19:31:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - January 31, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (the "Company" or "Moss") is pleased to announce that is has closed its previously announced non-brokered private placement of 2,500,000 common shares (each a "Share") at $0.10 per Share for total gross proceeds of $250,000 (the "Offering"). Concurrently, with the closing of the Offering, the Company announces closing of its acquisition of 160 Ethereum cryptocurrency ("ETH") in...